PerkinElmer is a multinational corporation that provides innovative solutions and technologies for diagnostics, life sciences, and applied services. The company was founded in 1937 by Richard Perkin and Charles Elmer, who combined their names to create the company's iconic name. Originally, PerkinElmer started as an optical design and manufacturing company, but over the years, it diversified and expanded its portfolio to cover various scientific and healthcare sectors.
PerkinElmer's primary focus is on delivering advanced technologies and solutions that support better health outcomes and drive scientific discoveries. Their products and services span a wide range of applications, including genetic testing, drug discovery and development, environmental monitoring, food safety, and more. The company serves customers in various industries, such as academic institutions, pharmaceutical companies, biotechnology firms, clinical laboratories, and government agencies.
As a global company, PerkinElmer has a presence in over 150 countries, with operations and research facilities in key regions around the world. They have acquired numerous companies over the years to complement their expertise and expand their capabilities in different areas, reinforcing their position as a leading player in the life sciences and diagnostics sectors.
PerkinElmer is a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol "PKI." It is also a component of the S&P 500 index, reflecting its significance in the healthcare and scientific industries. The company's commitment to innovation and research has enabled them to develop cutting-edge technologies that empower researchers, clinicians, and customers in their quest to make the world healthier and safer.
In addition to their product and service offerings, PerkinElmer is also involved in various partnerships and collaborations with academic institutions, research organizations, and industry partners to advance scientific knowledge and address critical global challenges. Through their comprehensive portfolio and dedication to advancing science and healthcare, PerkinElmer continues to play a significant role in shaping the future of diagnostics and life sciences worldwide.